Aranda P, Lopez de Novales E
Hypertension Unit, Regional Hospital, Malaga, Spain.
Am J Cardiol. 1990 May 2;65(17):72H-76H. doi: 10.1016/0002-9149(90)90348-5.
Diuretics are still among the most frequently used antihypertensive drugs in the treatment of hypertension. Their pharmacologic and hemodynamic properties are based on the water and salt metabolism in the pathophysiology of high blood pressure. Initially, there is a reduction of plasma and extracellular fluid volume; cardiac output also decreases. After this early phase, cardiac output returns to normal with an accompanying decrease in peripheral resistance so as to correct the underlying hemodynamic fault of the hypertensive state. Diuretics have a high therapeutic efficacy either as monotherapy or in combination with beta blockers, angiotensin-converting enzyme inhibitors or calcium antagonists. The main problem with the use of diuretics is related to their metabolic side effects, which are dose-related. Currently, there is a tendency to administer low-dose diuretics, which result in fewer clinical and metabolic side effects, but with a continued antihypertensive efficacy. Therefore, low doses of diuretics can be recommended as initial therapy in the stepped-care approach of hypertension.
利尿剂仍然是治疗高血压最常用的抗高血压药物之一。它们的药理和血流动力学特性基于高血压病理生理学中的水盐代谢。最初,血浆和细胞外液量减少;心输出量也降低。在这个早期阶段之后,心输出量恢复正常,同时外周阻力降低,以纠正高血压状态下潜在的血流动力学异常。利尿剂作为单一疗法或与β受体阻滞剂、血管紧张素转换酶抑制剂或钙拮抗剂联合使用时具有很高的治疗效果。使用利尿剂的主要问题与其代谢副作用有关,这些副作用与剂量相关。目前,倾向于使用低剂量利尿剂,其临床和代谢副作用较少,但仍具有持续的抗高血压疗效。因此,在高血压的阶梯式治疗方法中,低剂量利尿剂可作为初始治疗推荐。